Treace Unveils 5-Year Lapiplasty Data, New Findings at AOFAS

Treace Medical Concepts presented results from three clinical studies at this week’s American Orthopaedic Foot & Ankle Society (AOFAS) annual meeting on ALIGN3D Lapiplasty, MTA3D Adductoplasty, and the SPRINT SpeedPlate.

“We are proud to present a robust body of clinical evidence at AOFAS 2026 that continues to reinforce the durability and clinical value of our flagship procedures and technologies,” said John T. Treace, the Ponte Verda, Florida-based company’s founder, CEO, and chairman.

ALIGN3D Lapiplasty study

Daniel Farber, MD, of Lehigh Valley Orthopedic Institute, presented five-year results from a study of triplanar tarsometatarsal arthrodesis using the ALIGN3D Lapiplasty procedure. The final analysis showed an average return to weight bearing in a walking boot at 8.4 days, five-year radiographic recurrence rates of 0.8% using HVA >20° and 5.3% using HVA >15°, and sustained clinically significant improvements in MOxFQ and PROMIS scores.

The ALIGN3D post-market study evaluated the Lapiplasty 3D Bunion Correction Procedure in 173 patients with symptomatic hallux valgus across seven U.S. sites. The study assessed three-dimensional correction, durability after early weight bearing, healing, pain, quality of life, range of motion, and time to weight bearing in boots and shoes.

MTA3D Adductoplasty study

Mark Easley, MD, of Duke University, highlighted two-year interim results from a multicenter prospective study evaluating combined Adductoplasty and Lapiplasty procedures for metatarsus adductus and hallux valgus. Results showed an average return to weight bearing in a walking boot at 7.6 days, sustained radiographic correction through 24 months, and clinically significant improvements in pain and patient-reported outcomes.

The MTA3D post-market study evaluated combined Adductoplasty and Lapiplasty procedures in up to 66 patients with metatarsus adductus and hallux valgus. The study assessed sustained radiographic correction, healing, weight-bearing timelines, pain, quality of life, and big-toe range of motion over two years.

SPRINT SpeedPlate study

Jody McAleer, DPM, of Jefferson City Medical Group, shared one-year results from a multicenter study of SpeedPlate rapid compression implants for MTP and/or TMT arthrodesis. 96.6% of patients achieved clinical and radiographic union at 12 months, with an average return to weight bearing of 9 days. Patients with hallux valgus also showed significant radiographic correction by six weeks that was maintained through 12 months.

The post-market SPRINT study evaluated healing and union rates after joint fixation with SpeedPlate rapid compression implants, including the impact of early weight bearing. The primary endpoint was clinical and radiographic healing at 12 months, with secondary measures including radiographic alignment, weight-bearing timelines, pain, and patient satisfaction.

“The 5-year ALIGN3D data represents a first-in-industry milestone, demonstrating sustained, positive outcomes following the Lapiplasty Procedure,” said Treace. “Complementing this are our 2-year MTA3D interim results and SPRINT study results that further validate our technologies. Together, these studies underscore our commitment to generating high-quality, prospective clinical evidence that differentiates our technologies and supports better outcomes for patients.”

In June, the company reported the first case using its HyperPlate XM dynamic compression locking implant.